Eli & Co Lilly, 10% Owner at Zymeworks Inc. (ZYME), sold 250,000 shares at $16.00 ($4.0M) on 2019-01-31, disclosed to the SEC on 2019-02-04.
Open-market sale of $4.0M ZYME by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| Filing → |
| ZYME | SELL | 2018-09-20 | $200K | — | Filing → |
| ZYME | SELL | 2018-09-18 | $463K | — | Filing → |
| ZYME | SELL | 2018-09-14 | $598K | — | Filing → |